AstraZeneca PLC Asks Court Not to Revive Whistle-Blower Suit

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca Plc (AZN) and Bristol-Myers Squibb Co. (BMY:US) urged a Philadelphia federal appeals court not to revive a 10-year-old lawsuit alleging the drugmakers paid kickbacks to benefits manager Medco Health Solutions Inc. A lower court in January dismissed the whistle-blower case brought by Karl Schumann, a former Medco employee, ruling that his allegations were based on public information and he failed to show he had direct and independent knowledge of a scheme. Schumann simply sat in meetings, the companies said, calling his lawsuit “parasitic” in court filings.

Help employers find you! Check out all the jobs and post your resume.

Back to news